Showing results (451-460 of 478) with videos related to
Sort By:
Pageof 48
American Heart Journal|February 23, 2024
Angiographic characteristics of patients with STEMI and COVID-19: Insights from NACMI registryPayam Dehghani, Jyotpal Singh, G B John Mancini, et al.Circulation Research|April 29, 2018
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure)Roberto Bolli, Joshua M Hare, Keith L March, et al.The American Journal of Cardiology|March 6, 2024
SYNERGY-Everolimus-Eluting Stent With a Bioabsorbable Polymer in ST-Elevation Myocardial Infarction: CLEAR SYNERGY OASIS-9 RegistrySanjit S Jolly, Shun Fu Lee, Rajibul Mian, et al.Journal of the American College of Cardiology|May 21, 2022
Definitions and Standardized Endpoints for Treatment of Coronary BifurcationsMattia Lunardi, Yves Louvard, Thierry Lefèvre, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 18, 2022
Definitions and Standardized Endpoints for Treatment of Coronary BifurcationsMattia Lunardi, Yves Louvard, Thierry Lefèvre, et al.Circulation Research|November 9, 2016
PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMIArshed A Quyyumi, Alejandro Vasquez, Dean J Kereiakes, et al.Journal of the Society for Cardiovascular Angiography & Interventions|July 18, 2022
North American COVID-19 Myocardial Infarction (NACMI) Risk Score for Prediction of In-Hospital MortalityPayam Dehghani, Christian W Schmidt, Santiago Garcia, et al.Cell Transplantation|November 22, 2015
Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN TrialDoris A Taylor, Emerson C Perin, James T Willerson, et al.Circulation|June 15, 2007
Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trialDouglas W Losordo, Richard A Schatz, Christopher J White, et al.American Heart Journal|August 10, 2010
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and designJames T Willerson, Emerson C Perin, Stephen G Ellis, et al.Pageof 48